Section Arrow
Quote
PBH.NYSE
- Prestige Consumer Healthcare
Quotes are at least 15-min delayed:2026/06/02 18:46 EDT
After Hours
Last
 45.83
0 (0.00%)
Bid
45.54
Ask
46.11
High 45.83 
Low 44.96 
Volume 14.05K 
Regular Hours (Closed)
Last
 45.83
-0.12 (-0.26%)
Day High 
46.29 
Prev. Close
45.95 
1-M High
56.593 
Volume 
662.40K 
Bid
45.54
Ask
46.11
Day Low
44.75 
Open
45.46 
1-M Low
42.62 
Market Cap 
2.18B 
Currency 美元 
P/E 11.72 
%Yield 1.04 
10-SMA 47.47 
20-SMA 49.64 
50-SMA 54.55 
52-W High 87.12 
52-W Low 42.62 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.91/4.78
Enterprise Value
3.21B
Balance Sheet
Book Value Per Share
39.84
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
1.09B
Operating Revenue Per Share
23.79
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health27.51-0.25-0.90%-- 
After Hours 27.45 -0.06 -0.22%
ESPREsperion Therapeutics3.14+0.01+0.32%-- 
After Hours 3.1399 -0.0001 0.00%
SBFMSunshine Biopharma Inc2.6+0.21+8.79%-- 
After Hours 2.81 +0.21 +8.08%
TEVATeva Pharmaceutical Industries Limited33.08-1.56-4.50%24.69PE
After Hours 32.8433 -0.2367 -0.72%
VTRSViatris15.69-0.12-0.76%-- 
After Hours 15.84 +0.15 +0.96%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.